Mechanism of miR-21 Antagonist Packaged with Arsenic Trioxide (As2O3) Nanoparticles in Restraining Invasion and Metastasis of Intestinal Cancer by Targeted C-C Motif Chemokine Receptor 7 (CCR7) Protein Through Induction of PI3K/Akt Signal Pathway

Author:

Xu Jian1,Yin Mindi1,Zhao Jian1,Xu Chao1,Mao Zihan1

Affiliation:

1. Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, 110000, Liaoning, China

Abstract

Our study assessed mechanism of miR-21 antagonist packaged with arsenic trioxide nanoparticles (As2O3) in restraining invasion and metastasis of intestinal cancer by targeted CCR7 protein through induction of PI3K/Akt signal pathway. SW480 cell strains were adopted and divided into blank group, group with empty carrier, group with miR-21 agonist and group with miR-21 antagonist packaged with nanoparticles. Cell invasion and metastasis was observed after they were interfered with miR-21 agonist. Expressions of N-cadherin, Vimentin, MMP-9, MMP-2, PI3K and Akt were detected and targeted correlation between miR-21 and CCR7 was studied. The quantity of cells cross matrix membrane in group with carrier and miR-21 antagonist was lowest, while the quantity in the agonist group was highest. The expressions of N-cadherin, Vimentin, MMP-9, MMP-2, PI3K and Akt in group with carrier and antagonist were lower than in the other three groups, and expression of-cadherin and CCR-7 was reversed. The expression of CCR7 was up-regulated by the miR-21 antagonist packaged with nanoparticles, while activated degree of PI3K/Akt was restrained. The level of pathway factor was reduced abnormally so as to regulate the EMT procession, and expression of E-cadherin was increased. Moreover, the expression of MMP-9 and MMP-2 was reduced, and cell invasion and metastasis were controlled. The molecular mechanism was related with PI3K/AKt signal pathway.

Publisher

American Scientific Publishers

Subject

General Materials Science

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3